Patent · US Active

Water-soluble polymer-based cantharimides as potentially selective anti-tumor agents

US8344007B2 · kind B2 · utility

59Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 23, 2009
Grant dateJan 1, 2013
Priority date
Expiry dateOct 26, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A cantharimide compound may include the backbone of formula (1). R1, R2, R3, and R4 may be independently selected from the group consisting of H, C(O)OR5, C(O)R6, C(O)NR7R8, NR9C(O)R10, N—R11R12, O—R13, S—R14, P(O)(OR15)(OR16), As(O)(OR17)(OR18), SO2R19, SO3R20, and B(OR21). X1 to X4 may be independently selected from the group consisting of nitrogen and carbon, such that X1 to X4 are not all hydrogen. Y1, Y2 and R5 to R21 may be independently selected from the group consisting of hydrogen, C1-12-alkyl, -aryl, heteroaryl, and a bioactive polymer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.